Prognostic Factors
Cross-source consensus on Prognostic Factors from 1 sources and 6 claims.
1 sources · 6 claims
Risks & contraindications
Evidence quality
Highlighted claims
- B-symptoms independently predicted poorer survival in multivariable Cox regression. — Treatment adherence, survival outcomes and barriers to care of non-Hodgkin lymphoma in Northwest Ethiopia: a mixed-methods study
- High-intermediate International Prognostic Index was associated with increased mortality. — Treatment adherence, survival outcomes and barriers to care of non-Hodgkin lymphoma in Northwest Ethiopia: a mixed-methods study
- High International Prognostic Index carried the greatest mortality risk among measured predictors. — Treatment adherence, survival outcomes and barriers to care of non-Hodgkin lymphoma in Northwest Ethiopia: a mixed-methods study
- Survival differed significantly by disease grade, International Prognostic Index category, and presence of B-symptoms. — Treatment adherence, survival outcomes and barriers to care of non-Hodgkin lymphoma in Northwest Ethiopia: a mixed-methods study
- Patients without B-symptoms had better survival probabilities than patients with B-symptoms. — Treatment adherence, survival outcomes and barriers to care of non-Hodgkin lymphoma in Northwest Ethiopia: a mixed-methods study
- The International Prognostic Index retained prognostic value in this resource-limited setting. — Treatment adherence, survival outcomes and barriers to care of non-Hodgkin lymphoma in Northwest Ethiopia: a mixed-methods study